Transcriptional regulatory networks in lipid metabolism control ABCA1 expression

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1735, Issue 1, 2005, Pages 1-19

  Schmitz, Gerd ^a   Langmann, Thomas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

ABCA1; ABCG1; Lipid transport; Nuclear receptor; Oxysterols; Retinoid; Sterol regulatory element binding protein; ZNF202

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; BETA2 SYNTROPHIN; BIOLOGICAL FACTOR; CYTOKINE; FATTY ACID; HIGH DENSITY LIPOPROTEIN; HORMONE; HYPOXIA INDUCED FACTOR 1; LIGAND; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOLIPID; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN; PROTEIN ABCG1; PROTEIN CDC42; PROTEIN LIN7; PROTEIN ZNF202; REGULATOR PROTEIN; RETINOIC ACID RECEPTOR; RETINOID; STEROL; SYNTROPHIN; UNCLASSIFIED DRUG;

E BOX ELEMENT; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HOMEOSTASIS; LIPID METABOLISM; LIPID TRANSPORT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIPID METABOLISM; LIPOPROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 20444477132     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2005.04.004     Document Type: Review

References (200)

1. R. Ross Atherosclerosis-An inflammatory disease N. Engl. J. Med. 340 1999 115 126
2. D.R. Greaves, and S. Gordon Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors J. Lipid Res. 46 2005 11 20
3. S.R. Han, A. Momeni, K. Strach, P. Suriyaphol, D. Fenske, K. Paprotka, S.I. Hashimoto, M. Torzewski, S. Bhakdi, and M. Husmann Enzymatically modified LDL induces cathepsin H in human monocytes: potential relevance in early atherogenesis Arterioscler., Thromb., Vasc. Biol. 23 2003 661 667
4. G.K. Hansson Immune mechanisms in atherosclerosis Arterioscler., Thromb., Vasc. Biol. 21 2001 1876 1890
5. G. Schmitz, W.E. Kaminski, and E. Orso ABC transporters in cellular lipid trafficking Curr. Opin. Lipidol. 11 2000 493 501
6. G. Schmitz, T. Langmann, and S. Heimerl Role of ABCG1 and other ABCG family members in lipid metabolism J. Lipid Res. 42 2001 1513 1520
7. G. Schmitz, and T. Langmann Structure, function and regulation of the ABC1 gene product Curr. Opin. Lipidol. 12 2001 129 140
8. M. Bodzioch, E. Orso, J. Klucken, T. Langmann, A. Bottcher, W. Diederich, W. Drobnik, S. Barlage, C. Buchler, M. Porsch-Ozcurumez, W.E. Kaminski, H.W. Hahmann, K. Oette, G. Rothe, C. Aslanidis, K.J. Lackner, and G. Schmitz The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease Nat. Genet. 22 1999 347 351
9. A. Brooks-Wilson, M. Marcil, S.M. Clee, L.H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J.A. Collins, H.O. Molhuizen, O. Loubser, B.F. Ouelette, K. Fichter, K.J. Ashbourne-Excoffon, C.W. Sensen, S. Scherer, S. Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J.J. Kastelein, and M.R. Hayden Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency Nat. Genet. 22 1999 336 345
10. S. Rust, M. Rosier, H. Funke, J. Real, Z. Amoura, J.C. Piette, J.F. Deleuze, H.B. Brewer, N. Duverger, P. Denefle, and G. Assmann Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 Nat. Genet. 22 1999 352 355
11. K.E. Berge, H. Tian, G.A. Graf, L. Yu, N.V. Grishin, J. Schultz, P. Kwiterovich, B. Shan, R. Barnes, and H.H. Hobbs Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters Science 290 2000 1771 1775
12. M.H. Lee, K. Lu, S. Hazard, H. Yu, S. Shulenin, H. Hidaka, H. Kojima, R. Allikmets, N. Sakuma, R. Pegoraro, A.K. Srivastava, G. Salen, M. Dean, and S.B. Patel Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption Nat. Genet. 27 2001 79 83
13. G. Millat, K. Chikh, S. Naureckiene, D.E. Sleat, A.H. Fensom, K. Higaki, M. Elleder, P. Lobel, and M.T. Vanier Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group Am. J. Hum. Genet. 69 2001 1013 1021
14. M.T. Vanier, and G. Millat Niemann-Pick disease type C Clin. Genet. 64 2003 269 281
15. E. Orso, C. Broccardo, W.E. Kaminski, A. Bottcher, G. Liebisch, W. Drobnik, A. Gotz, O. Chambenoit, W. Diederich, T. Langmann, T. Spruss, M.F. Luciani, G. Rothe, K.J. Lackner, G. Chimini, and G. Schmitz Transport of lipids from Golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice Nat. Genet. 24 2000 192 196
16. X. Zha, A. Gauthier, J. Genest, and R. McPherson Secretory vesicular transport from the Golgi is altered during ATP-binding cassette protein A1 (ABCA1)-mediated cholesterol efflux J. Biol. Chem. 278 2003 10002 10005
17. J. Klucken, C. Buchler, E. Orso, W.E. Kaminski, M. Porsch-Ozcurumez, G. Liebisch, M. Kapinsky, W. Diederich, W. Drobnik, M. Dean, R. Allikmets, and G. Schmitz ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport Proc. Natl. Acad. Sci. U. S. A. 97 2000 817 822
18. A. van Helvoort, A.J. Smith, H. Sprong, I. Fritzsche, A.H. Schinkel, P. Borst, and G. van Meer MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine Cell 87 1996 507 517
19. A.J. Brown, G.F. Watts, J.R. Burnett, R.T. Dean, and W. Jessup Sterol 27-hydroxylase acts on 7-ketocholesterol in human atherosclerotic lesions and macrophages in culture J. Biol. Chem. 275 2000 27627 27633
20. I. Bjorkhem, U. Diczfalusy, and D. Lutjohann Removal of cholesterol from extrahepatic sources by oxidative mechanisms Curr. Opin. Lipidol. 10 1999 161 165
21. H. Kolsch, R. Heun, A. Kerksiek, K.V. Bergmann, W. Maier, and D. Lutjohann Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients Neurosci. Lett. 368 2004 303 308
22. I. Bjorkhem, and S. Meaney Brain cholesterol: long secret life behind a barrier Arterioscler., Thromb., Vasc. Biol. 24 2004 806 815
23. T. Langmann, J. Klucken, M. Reil, G. Liebisch, M.F. Luciani, G. Chimini, W.E. Kaminski, and G. Schmitz Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages Biochem. Biophys. Res. Commun. 257 1999 29 33
24. H. Liao, T. Langmann, G. Schmitz, and Y. Zhu Native LDL upregulation of ATP-binding cassette transporter-1 in human vascular endothelial cells Arterioscler., Thromb., Vasc. Biol. 22 2002 127 132
25. S. Shulenin, L.M. Nogee, T. Annilo, S.E. Wert, J.A. Whitsett, and M. Dean ABCA3 gene mutations in newborns with fatal surfactant deficiency N. Engl. J. Med. 350 2004 1296 1303
26. M.H. Lee, K. Lu, and S.B. Patel Genetic basis of sitosterolemia Curr. Opin. Lipidol. 12 2001 141 149
27. L. Bellincampi, M.L. Simone, C. Motti, C. Cortese, S. Bernardini, S. Bertolini, and S. Calandra Identification of an alternative transcript of ABCA1 gene in different human cell types Biochem. Biophys. Res. Commun. 283 2001 590 597
28. J. Huuskonen, M. Abedin, M. Vishnu, C.R. Pullinger, S.E. Baranzini, J.P. Kane, P.E. Fielding, and C.J. Fielding Dynamic regulation of alternative ATP-binding cassette transporter A1 transcripts Biochem. Biophys. Res. Commun. 306 2003 463 468
29. A.J. Mendez, G. Lin, D.P. Wade, R.M. Lawn, and J.F. Oram Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway J. Biol. Chem. 276 2001 3158 3166
30. W. Drobnik, H. Borsukova, A. Bottcher, A. Pfeiffer, G. Liebisch, G.J. Schutz, H. Schindler, and G. Schmitz Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains Traffic 3 2002 268 278
31. L.O. Martinez, B. Agerholm-Larsen, N. Wang, W. Chen, and A.R. Tall Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I J. Biol. Chem. 278 2003 37368 37374
32. N. Wang, W. Chen, P. Linsel-Nitschke, L.O. Martinez, B. Agerholm-Larsen, D.L. Silver, and A.R. Tall A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I J. Clin. Invest. 111 2003 99 107
33. S. Roosbeek, F. Peelman, A. Verhee, C. Labeur, H. Caster, M.F. Lensink, C. Cirulli, J. Grooten, C. Cochet, J. Vandekerckhove, A. Amoresano, G. Chimini, J. Tavernier, and M. Rosseneu Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter J. Biol. Chem. 279 2004 37779 37788
34. C. Tang, A.M. Vaughan, and J.F. Oram Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol J. Biol. Chem. 279 2004 7622 7628
35. G. Szakacs, T. Langmann, C. Ozvegy, E. Orso, G. Schmitz, A. Varadi, and B. Sarkadi Characterization of the ATPase cycle of human ABCA1: implications for its function as a regulator rather than an active transporter Biochem. Biophys. Res. Commun. 288 2001 1258 1264
36. W. Diederich, E. Orso, W. Drobnik, and G. Schmitz Apolipoprotein AI and HDL(3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42 Atherosclerosis 159 2001 313 324
37. K. Tsukamoto, K. Hirano, K. Tsujii, C. Ikegami, Z. Zhongyan, Y. Nishida, T. Ohama, F. Matsuura, S. Yamashita, and Y. Matsuzawa ATP-binding cassette transporter-1 induces rearrangement of actin cytoskeletons possibly through Cdc42/N-WASP Biochem. Biophys. Res. Commun. 287 2001 757 765
38. C. Buechler, A. Boettcher, S.M. Bared, M.C. Probst, and G. Schmitz The carboxyterminus of the ATP-binding cassette transporter A1 interacts with a beta2-syntrophin/utrophin complex Biochem. Biophys. Res. Commun. 293 2002 759 765
39. Y. Munehira, T. Ohnishi, S. Kawamoto, A. Furuya, K. Shitara, M. Imamura, T. Yokota, S. Takeda, T. Amachi, M. Matsuo, N. Kioka, and K. Ueda Alpha1-syntrophin modulates turnover of ABCA1 J. Biol. Chem. 279 2004 15091 15095
40. T. Engel, A. Lueken, G. Bode, U. Hobohm, S. Lorkowski, B. Schlueter, S. Rust, P. Cullen, M. Pech, G. Assmann, and U. Seedorf ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol export FEBS Lett. 566 2004 241 246
41. S.M. Bared, C. Buechler, A. Boettcher, R. Dayoub, A. Sigruener, M. Grandl, C. Rudolph, A. Dada, and G. Schmitz Association of ABCA1 with syntaxin 13 and flotillin-1 and enhanced phagocytosis in tangier cells Mol. Biol. Cell 15 2004 5399 5407
42. L. Huang, Y.M. Kuo, and J. Gitschier The pallid gene encodes a novel, syntaxin 13-interacting protein involved in platelet storage pool deficiency Nat. Genet. 23 1999 329 332
43. J.R. Nofer, G. Herminghaus, M. Brodde, E. Morgenstern, S. Rust, T. Engel, U. Seedorf, G. Assmann, H. Bluethmann, and B.E. Kehrel Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease) J. Biol. Chem. 279 2004 34032 34037
44. J. Cserepes, Z. Szentpetery, L. Seres, C. Ozvegy-Laczka, T. Langmann, G. Schmitz, H. Glavinas, I. Klein, L. Homolya, A. Varadi, B. Sarkadi, and N.B. Elkind Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization Biochem. Biophys. Res. Commun. 320 2004 860 867
45. N. Wang, D. Lan, W. Chen, F. Matsuura, and A.R. Tall ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins Proc. Natl. Acad. Sci. U. S. A. 101 2004 9774 9779
46. K. Nakamura, M.A. Kennedy, A. Baldan, D.D. Bojanic, K. Lyons, and P.A. Edwards Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein J. Biol. Chem. 279 2004 45980 45989
47. Y. Wang, and J.F. Oram Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1 J. Biol. Chem. 277 2002 5692 5697
48. C.L. Wellington, E.K. Walker, A. Suarez, A. Kwok, N. Bissada, R. Singaraja, Y.Z. Yang, L.H. Zhang, E. James, J.E. Wilson, O. Francone, B.M. McManus, and M.R. Hayden ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation Lab. Invest. 82 2002 273 283
49. C. Song, J.M. Kokontis, R.A. Hiipakka, and S. Liao Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors Proc. Natl. Acad. Sci. U. S. A. 91 1994 10809 10813
50. P.A. Edwards, H.R. Kast, and A.M. Anisfeld BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis J. Lipid Res. 43 2002 2 12
51. P.J. Willy, K. Umesono, E.S. Ong, R.M. Evans, R.A. Heyman, and D.J. Mangelsdorf LXR, a nuclear receptor that defines a distinct retinoid response pathway Genes Dev. 9 1995 1033 1045
52. J.J. Repa, and D.J. Mangelsdorf Nuclear receptor regulation of cholesterol and bile acid metabolism Curr. Opin. Biotechnol. 10 1999 557 563
53. G.U. Schuster, P. Parini, L. Wang, S. Alberti, K.R. Steffensen, G.K. Hansson, B. Angelin, and J.A. Gustafsson Accumulation of foam cells in liver X receptor-deficient mice Circulation 106 2002 1147 1153
54. R.K. Tangirala, E.D. Bischoff, S.B. Joseph, B.L. Wagner, R. Walczak, B.A. Laffitte, C.L. Daige, D. Thomas, R.A. Heyman, D.J. Mangelsdorf, X. Wang, A.J. Lusis, P. Tontonoz, and I.G. Schulman Identification of macrophage liver X receptors as inhibitors of atherosclerosis Proc. Natl. Acad. Sci. U. S. A. 99 2002 11896 11901
55. D.S. Ory Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home? Circ. Res. 95 2004 660 670
56. P. Costet, Y. Luo, N. Wang, and A.R. Tall Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor J. Biol. Chem. 275 2000 28240 28245
57. M.A. Kennedy, A. Venkateswaran, P.T. Tarr, I. Xenarios, J. Kudoh, N. Shimizu, and P.A. Edwards Characterization of the human abcg1 gene. liver x receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein J. Biol. Chem. 276 2001 39438 39447
58. R.P. Koldamova, I.M. Lefterov, M.D. Ikonomovic, J. Skoko, P.I. Lefterov, B.A. Isanski, S.T. DeKosky, and J.S. Lazo 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion J. Biol. Chem. 278 2003 13244 13256
59. S. Murthy, E. Born, S.N. Mathur, and F.J. Field LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells J. Lipid Res. 43 2002 1054 1064
60. K. Schwartz, R.M. Lawn, and D.P. Wade ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR Biochem. Biophys. Res. Commun. 274 2000 794 802
61. B. Mascrez, N.B. Ghyselinck, M. Watanabe, J.S. Annicotte, P. Chambon, J. Auwerx, and M. Mark Ligand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells EMBO Rep. 5 2004 285 290
62. B.A. Janowski, P.J. Willy, T.R. Devi, J.R. Falck, and D.J. Mangelsdorf An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha Nature 383 1996 728 731
63. E.G. Lund, J.G. Menke, and C.P. Sparrow Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis Arterioscler., Thromb., Vasc. Biol. 23 2003 1169 1177
64. X. Fu, J.G. Menke, Y. Chen, G. Zhou, K.L. MacNaul, S.D. Wright, C.P. Sparrow, and E.G. Lund 27-Hydroxycholesterol is an endogenous ligand for LXR in cholesterol-loaded cells J. Biol. Chem. 276 2001 38378 38387
65. S. Dzeletovic, O. Breuer, E. Lund, and U. Diczfalusy Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry Anal. Biochem. 225 1995 73 80
66. T.A. Spencer, D. Li, J.S. Russel, J.L. Collins, R.K. Bledsoe, T.G. Consler, L.B. Moore, C.M. Galardi, D.D. McKee, J.T. Moore, M.A. Watson, D.J. Parks, M.H. Lambert, and T.M. Willson Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha J. Med. Chem. 44 2001 886 897
67. C.P. Sparrow, J. Baffic, M.H. Lam, E.G. Lund, A.D. Adams, X. Fu, N. Hayes, A.B. Jones, K.L. MacNaul, J. Ondeyka, S. Singh, J. Wang, G. Zhou, D.E. Moller, S.D. Wright, and J.G. Menke A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux J. Biol. Chem. 277 2002 10021 10027
68. B.A. Laffitte, S.B. Joseph, R. Walczak, L. Pei, D.C. Wilpitz, J.L. Collins, and P. Tontonoz Autoregulation of the human liver X receptor alpha promoter Mol. Cell. Biol. 21 2001 7558 7568
69. A. Grefhorst, B.M. Elzinga, P.J. Voshol, T. Plosch, T. Kok, V.W. Bloks, F.H. Van Der Sluijs, L.M. Havekes, J.A. Romijn, H.J. Verkade, and F. Kuipers Stimulation of lipogenesis by pharmacological activation of the liver X receptor (LXR) leads to production of large, triglyceride-rich VLDL particles J. Biol. Chem. 277 2002 34182 34190
70. S.B. Joseph, E. McKilligin, L. Pei, M.A. Watson, A.R. Collins, B.A. Laffitte, M. Chen, G. Noh, J. Goodman, G.N. Hagger, J. Tran, T.K. Tippin, X. Wang, A.J. Lusis, W.A. Hsueh, R.E. Law, J.L. Collins, T.M. Willson, and P. Tontonoz Synthetic LXR ligand inhibits the development of atherosclerosis in mice Proc. Natl. Acad. Sci. U. S. A. 99 2002 7604 7609
71. J.R. Schultz, H. Tu, A. Luk, J.J. Repa, J.C. Medina, L. Li, S. Schwendner, S. Wang, M. Thoolen, D.J. Mangelsdorf, K.D. Lustig, and B. Shan Role of LXRs in control of lipogenesis Genes Dev. 14 2000 2831 2838
72. S.B. Joseph, B.A. Laffitte, P.H. Patel, M.A. Watson, K.E. Matsukuma, R. Walczak, J.L. Collins, T.F. Osborne, and P. Tontonoz Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors J. Biol. Chem. 277 2002 11019 11025
73. J.J. Repa, G. Liang, J. Ou, Y. Bashmakov, J.M. Lobaccaro, I. Shimomura, B. Shan, M.S. Brown, J.L. Goldstein, and D.J. Mangelsdorf Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta Genes Dev. 14 2000 2819 2830
74. T. Yoshikawa, H. Shimano, M. Amemiya-Kudo, N. Yahagi, A.H. Hasty, T. Matsuzaka, H. Okazaki, Y. Tamura, Y. Iizuka, K. Ohashi, J. Osuga, K. Harada, T. Gotoda, S. Kimura, S. Ishibashi, and N. Yamada Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter Mol. Cell. Biol. 21 2001 2991 3000
75. D.J. Peet, S.D. Turley, W. Ma, B.A. Janowski, J.M. Lobaccaro, R.E. Hammer, and D.J. Mangelsdorf Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha Cell 93 1998 693 704
76. L. Wang, G.U. Schuster, K. Hultenby, Q. Zhang, S. Andersson, and J.A. Gustafsson Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration Proc. Natl. Acad. Sci. U. S. A. 99 2002 13878 13883
77. D.M. Selva, V. Hirsch-Reinshagen, B. Burgess, S. Zhou, J. Chan, S. McIsaac, M.R. Hayden, G.L. Hammond, A.W. Vogl, and C.L. Wellington The ATP-binding cassette transporter 1 mediates lipid efflux from Sertoli cells and influences male fertility J. Lipid Res. 45 2004 1040 1050
78. J.L. Collins, A.M. Fivush, M.A. Watson, C.M. Galardi, M.C. Lewis, L.B. Moore, D.J. Parks, J.G. Wilson, T.K. Tippin, J.G. Binz, K.D. Plunket, D.G. Morgan, E.J. Beaudet, K.D. Whitney, S.A. Kliewer, and T.M. Willson Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines J. Med. Chem. 45 2002 1963 1966
79. B. Miao, S. Zondlo, S. Gibbs, D. Cromley, V.P. Hosagrahara, T.G. Kirchgessner, J. Billheimer, and R. Mukherjee Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator J. Lipid Res. 45 2004 1410 1417
80. E.M. Quinet, D.A. Savio, A.R. Halpern, L. Chen, C.P. Miller, and P. Nambi Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor J. Lipid Res. 45 2004 1929 1942
81. Y. Luo, and A.R. Tall Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element J. Clin. Invest. 105 2000 513 520
82. E.M. Quinet, L.B. Agellon, P.A. Kroon, Y.L. Marcel, Y.C. Lee, M.E. Whitlock, and A.R. Tall Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver J. Clin. Invest. 85 1990 357 363
83. J.M. Lehmann, S.A. Kliewer, L.B. Moore, T.A. Smith-Oliver, B.B. Oliver, J.L. Su, S.S. Sundseth, D.A. Winegar, D.E. Blanchard, T.A. Spencer, and T.M. Willson Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway J. Biol. Chem. 272 1997 3137 3140
84. J.Y. Chen, B. Levy-Wilson, S. Goodart, and A.D. Cooper Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lack induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet J. Biol. Chem. 277 2002 42588 42595
85. H. Esterbauer, J. Gebicki, H. Puhl, and G. Jurgens The role of lipid peroxidation and antioxidants in oxidative modification of LDL Free Radic. Biol. Med. 13 1992 341 390
86. J.L. Witztum, and D. Steinberg Role of oxidized low density lipoprotein in atherogenesis J. Clin. Invest. 88 1991 1785 1792
87. V. Giguere Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling Endocr. Rev. 15 1994 61 79
88. D.J. Mangelsdorf Vitamin A receptors Nutr. Rev. 52 1994 S32 S44
89. G. Allenby, M.T. Bocquel, M. Saunders, S. Kazmer, J. Speck, M. Rosenberger, A. Lovey, P. Kastner, J.F. Grippo, and P. Chambon Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids Proc. Natl. Acad. Sci. U. S. A. 90 1993 30 34
90. P. Chambon A decade of molecular biology of retinoic acid receptors FASEB J. 10 1996 940 954
91. T. Langmann, G. Liebisch, C. Moehle, R. Schifferer, R. Dayoub, S. Heiduczek, M. Grandl, A. Dada, G. Schmitz, Gene expression profiling identifies retinoids as potent inducers of macrophage lipid efflux, Biochim. Biophys. Acta (in press).
92. P. Costet, F. Lalanne, M.C. Gerbod-Giannone, J.R. Molina, X. Fu, E.G. Lund, L.J. Gudas, and A.R. Tall Retinoic acid receptor-mediated induction of ABCA1 in macrophages Mol. Cell. Biol. 23 2003 7756 7766
93. D. Wagsater, J. Dimberg, and A. Sirsjo Induction of ATP-binding cassette A1 by all-trans retinoic acid: possible role of liver X receptor-alpha Int. J. Mol. Med. 11 2003 419 423
94. A. Szanto, S. Benko, I. Szatmari, B.L. Balint, I. Furtos, R. Ruhl, S. Molnar, L. Csiba, R. Garuti, S. Calandra, H. Larsson, U. Diczfalusy, and L. Nagy Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages Mol. Cell. Biol. 24 2004 8154 8166
95. D.R. Soprano, P. Qin, and K.J. Soprano Retinoic acid receptors and cancers Annu. Rev. Nutr. 24 2004 201 221
96. J.B. Yang, Z.J. Duan, W. Yao, O. Lee, L. Yang, X.Y. Yang, X. Sun, C.C. Chang, T.Y. Chang, and B.L. Li Synergistic transcriptional activation of human Acyl-coenzyme A: cholesterol acyltransterase-1 gene by interferon-gamma and all-trans-retinoic acid THP-1 cells J. Biol. Chem. 276 2001 20989 20998
97. O. Barbier, I.P. Torra, Y. Duguay, C. Blanquart, J.C. Fruchart, C. Glineur, and B. Staels Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis Arterioscler., Thromb., Vasc. Biol. 22 2002 717 726
98. H. Lee, W. Shi, P. Tontonoz, S. Wang, G. Subbanagounder, C.C. Hedrick, S. Hama, C. Borromeo, R.M. Evans, J.A. Berliner, and L. Nagy Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells Circ. Res. 87 2000 516 521
99. M. Febbraio, E.A. Podrez, J.D. Smith, D.P. Hajjar, S.L. Hazen, H.F. Hoff, K. Sharma, and R.L. Silverstein Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice J. Clin. Invest. 105 2000 1049 1056
100. P. Tontonoz, L. Nagy, J.G. Alvarez, V.A. Thomazy, and R.M. Evans PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL Cell 93 1998 241 252
101. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
102. V. Pasceri, H.D. Wu, J.T. Willerson, and E.T. Yeh Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators Circulation 101 2000 235 238
103. A. Chawla, W.A. Boisvert, C.H. Lee, B.A. Laffitte, Y. Barak, S.B. Joseph, D. Liao, L. Nagy, P.A. Edwards, L.K. Curtiss, R.M. Evans, and P. Tontonoz A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis Mol. Cell 7 2001 161 171
104. G. Chinetti, J.C. Fruchart, and B. Staels Peroxisome proliferator- activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation Inflamm. Res. 49 2000 497 505
105. G. Chinetti, S. Lestavel, V. Bocher, A.T. Remaley, B. Neve, I.P. Torra, E. Teissier, A. Minnich, M. Jaye, N. Duverger, H.B. Brewer, J.C. Fruchart, V. Clavey, and B. Staels PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat. Med. 7 2001 53 58
106. A.C. Li, K.K. Brown, M.J. Silvestre, T.M. Willson, W. Palinski, and C.K. Glass Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice J. Clin. Invest. 106 2000 523 531
107. A.C. Li, C.J. Binder, A. Gutierrez, K.K. Brown, C.R. Plotkin, J.W. Pattison, A.F. Valledor, R.A. Davis, T.M. Willson, J.L. Witztum, W. Palinski, and C.K. Glass Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma J. Clin. Invest. 114 2004 1564 1576
108. W.R. Oliver Jr., J.L. Shenk, M.R. Snaith, C.S. Russell, K.D. Plunket, N.L. Bodkin, M.C. Lewis, D.A. Winegar, M.L. Sznaidman, M.H. Lambert, H.E. Xu, D.D. Sternbach, S.A. Kliewer, B.C. Hansen, and T.M. Willson A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport Proc. Natl. Acad. Sci. U. S. A. 98 2001 5306 5311
109. B.L. Knight, D.D. Patel, S.M. Humphreys, D. Wiggins, and G.F. Gibbons Inhibition of cholesterol absorption associated with a PPAR alpha-dependent increase in ABC binding cassette transporter A1 in mice J. Lipid Res. 44 2003 2049 2058
110. L. Zeng, H. Liao, Y. Liu, T.S. Lee, M. Zhu, X. Wang, M.B. Stemerman, Y. Zhu, and J.Y. Shyy Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism J. Biol. Chem. 279 2004 48801 48807
111. J.D. Horton, and I. Shimomura Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis Curr. Opin. Lipidol. 10 1999 143 150
112. T. Langmann, M. Porsch-Ozcurumez, S. Heimerl, M. Probst, C. Moehle, M. Taher, H. Borsukova, D. Kielar, W.E. Kaminski, E. Dittrich-Wengenroth, and G. Schmitz Identification of sterol-independent regulatory elements in the human ATP-binding cassette transporter A1 promoter: role of Sp1/3, E-box binding factors, and an oncostatin M-responsive element J. Biol. Chem. 277 2002 14443 14450
113. S. Santamarina-Fojo, K. Peterson, C. Knapper, Y. Qiu, L. Freeman, J.F. Cheng, J. Osorio, A. Remaley, X.P. Yang, C. Haudenschild, C. Prades, G. Chimini, E. Blackmon, T. Francois, N. Duverger, E.M. Rubin, M. Rosier, P. Denefle, D.S. Fredrickson, and H.B. Brewer Jr. Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter Proc. Natl. Acad. Sci. U. S. A. 97 2000 7987 7992
114. X.P. Yang, L.A. Freeman, C.L. Knapper, M.J. Amar, A. Remaley, H.B. Brewer Jr., and S. Santamarina-Fojo The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene J. Lipid Res. 43 2002 297 306
115. T. Lin, L. Zeng, Y. Liu, K. DeFea, M.A. Schwartz, S. Chien, and J.Y. Shyy Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins Circ. Res. 92 2003 1296 1304
116. Y. Liu, B.P. Chen, M. Lu, Y. Zhu, M.B. Stemerman, S. Chien, and J.Y. Shyy Shear stress activation of SREBP1 in endothelial cells is mediated by integrins Arterioscler., Thromb., Vasc. Biol. 22 2002 76 81
117. R.H. Unger Lipotoxic diseases Annu. Rev. Med. 53 2002 319 336
118. Y. Uehara, T. Engel, Z. Li, C. Goepfert, S. Rust, X. Zhou, C. Langer, C. Schachtrup, J. Wiekowski, S. Lorkowski, G. Assmann, and A. Von Eckardsteins Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1 Diabetes 51 2002 2922 2928
119. Y. Wang, B. Kurdi-Haidar, and J.F. Oram LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1 J. Lipid Res. 45 2004 972 980
120. Y. Sun, M. Hao, Y. Luo, C.P. Liang, D.L. Silver, C. Cheng, F.R. Maxfield, and A.R. Tall Stearoyl-CoA desaturase inhibits ATP-binding cassette transporter A1-mediated cholesterol efflux and modulates membrane domain structure J. Biol. Chem. 278 2003 5813 5820
121. J. Ou, H. Tu, B. Shan, A. Luk, R.A. DeBose-Boyd, Y. Bashmakov, J.L. Goldstein, and M.S. Brown Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR Proc. Natl. Acad. Sci. U. S. A. 98 2001 6027 6032
122. M. Teran-Garcia, C. Rufo, M.T. Nakamura, T.F. Osborne, and S.D. Clarke NF-Y involvement in the polyunsaturated fat inhibition of fatty acid synthase gene transcription Biochem. Biophys. Res. Commun. 290 2002 1295 1299
123. T. Yoshikawa, T. Ide, H. Shimano, N. Yahagi, M. Amemiya-Kudo, T. Matsuzaka, S. Yatoh, T. Kitamine, H. Okazaki, Y. Tamura, M. Sekiya, A. Takahashi, A.H. Hasty, R. Sato, H. Sone, J. Osuga, S. Ishibashi, and N. Yamada Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism: I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling Mol. Endocrinol. 17 2003 1240 1254
124. S.D. Clarke The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors Curr. Opin. Lipidol. 15 2004 13 18
125. X. Gan, R. Kaplan, J.G. Menke, K. MacNaul, Y. Chen, C.P. Sparrow, G. Zhou, S.D. Wright, and T.Q. Cai Dual mechanisms of ABCA1 regulation by geranylgeranyl pyrophosphate J. Biol. Chem. 276 2001 48702 48708
126. B.M. Forman, B. Ruan, J. Chen, G.J. Schroepfer Jr., and R.M. Evans The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism Proc. Natl. Acad. Sci. U. S. A. 94 1997 10588 10593
127. Y. Takai, T. Sasaki, and T. Matozaki Small GTP-binding proteins Physiol. Rev. 81 2001 153 208
128. G. Schmitz, and C. Buechler ABCA1: regulation, trafficking and association with heteromeric proteins Ann. Med. 34 2002 334 347
129. C.U. Chae, P.M. Ridker, and J.E. Manson Postmenopausal hormone replacement therapy and cardiovascular disease Thromb. Haemost. 78 1997 770 780
130. M. Gerhard, and P. Ganz How do we explain the clinical benefits of estrogen? From bedside to bench Circulation 92 1995 5 8
131. P.A. Bourassa, P.M. Milos, B.J. Gaynor, J.L. Breslow, and R.J. Aiello Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice Proc. Natl. Acad. Sci. U. S. A. 93 1996 10022 10027
132. J.B. Hodgin, J.H. Krege, R.L. Reddick, K.S. Korach, O. Smithies, and N. Maeda Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe -/- mice J. Clin. Invest. 107 2001 333 340
133. R.A. Srivastava, N. Srivastava, M. Averna, R.C. Lin, K.S. Korach, D.B. Lubahn, and G. Schonfeld Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway J. Biol. Chem. 272 1997 33360 33366
134. R.A. Srivastava Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen Mol. Cell. Biochem. 240 2002 67 73
135. J. Fukuchi, R.A. Hiipakka, J.M. Kokontis, S. Hsu, A.L. Ko, M.L. Fitzgerald, and S. Liao Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells Cancer Res. 64 2004 7682 7685
136. S.L. Ettinger, R. Sobel, T.G. Whitmore, M. Akbari, D.R. Bradley, M.E. Gleave, and C.C. Nelson Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence Cancer Res. 64 2004 2212 2221
137. J. Fukuchi, J.M. Kokontis, R.A. Hiipakka, C.P. Chuu, and S. Liao Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells Cancer Res. 64 2004 7686 7689
138. L.H. Duntas Thyroid disease and lipids Thyroid 12 2002 287 293
139. H. Gullberg, M. Rudling, D. Forrest, B. Angelin, and B. Vennstrom Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol Mol. Endocrinol. 14 2000 1739 1749
140. J. Huuskonen, M. Vishnu, C.R. Pullinger, P.E. Fielding, and C.J. Fielding Regulation of ATP-binding cassette transporter A1 transcription by thyroid hormone receptor Biochemistry 43 2004 1626 1632
141. C.K. Glass, and J.L. Witztum Atherosclerosis. The road ahead Cell 104 2001 503 516
142. M.V. Kalayoglu, P. Libby, and G.I. Byrne Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease JAMA 288 2002 2724 2731
143. M.V. Kalayoglu, and G.I. Byrne A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide Infect. Immun. 66 1998 5067 5072
144. S. Barlage, D. Frohlich, A. Bottcher, M. Jauhiainen, H.P. Muller, F. Noetzel, G. Rothe, C. Schutt, R.P. Linke, K.J. Lackner, C. Ehnholm, and G. Schmitz ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response J. Lipid Res. 42 2001 281 290
145. I. Baranova, T. Vishnyakova, A. Bocharov, Z. Chen, A.T. Remaley, J. Stonik, T.L. Eggerman, and A.P. Patterson Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells Infect. Immun. 70 2002 2995 3003
146. W. Khovidhunkit, A.H. Moser, J.K. Shigenaga, C. Grunfeld, and K.R. Feingold Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR J. Lipid Res. 44 2003 1728 1736
147. A.P. Beigneux, A.H. Moser, J.K. Shigenaga, C. Grunfeld, and K.R. Feingold The acute phase response is associated with retinoid X receptor repression in rodent liver J. Biol. Chem. 275 2000 16390 16399
148. C.G. Panousis, and S.H. Zuckerman Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells Arterioscler., Thromb., Vasc. Biol. 20 2000 1565 1571
149. X.Q. Wang, C.G. Panousis, M.L. Alfaro, G.F. Evans, and S.H. Zuckerman Interferon-gamma-mediated downregulation of cholesterol efflux and ABC1 expression is by the Stat1 pathway Arterioscler., Thromb., Vasc. Biol. 22 2002 e5 e9
150. C.G. Panousis, G. Evans, and S.H. Zuckerman TGF-beta increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: opposing the effects of IFN-gamma J. Lipid Res. 42 2001 856 863
151. S.H. Zuckerman, G.F. Evans, and L. O'Neal Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-beta Atherosclerosis 96 1992 203 214
152. J.A. McPherson, K.G. Barringhaus, G.G. Bishop, J.M. Sanders, J.M. Rieger, S.E. Hesselbacher, L.W. Gimple, E.R. Powers, T. Macdonald, G. Sullivan, J. Linden, and I.J. Sarembock Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model Arterioscler., Thromb., Vasc. Biol. 21 2001 791 796
153. K.N. Garratt, D.R. Holmes Jr., V. Molina-Viamonte, G.S. Reeder, D.O. Hodge, K.R. Bailey, J.K. Lobl, D.A. Laudon, and R.J. Gibbons Intravenous adenosine and lidocaine in patients with acute mycocardial infarction Am. Heart J. 136 1998 196 204
154. A.B. Reiss, M.M. Rahman, E.S. Chan, M.C. Montesinos, N.W. Awadallah, and B.N. Cronstein Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages J. Leukoc. Biol. 76 2004 727 734
155. M.J. Chapman, G. Assmann, J.C. Fruchart, J. Shepherd, and C. Sirtori Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid-A position paper developed by the European Consensus Panel on HDL-C Curr. Med. Res. Opin. 20 2004 1253 1268
156. D.J. Rader Regulation of reverse cholesterol transport and clinical implications Am. J. Cardiol. 92 2003 42J 49J
157. S. Malik, and M.L. Kashyap Niacin, lipids, and heart disease Curr. Cardiol. Rep. 5 2003 470 476
158. C.D. Meyers, V.S. Kamanna, and M.L. Kashyap Niacin therapy in atherosclerosis Curr. Opin. Lipidol. 15 2004 659 665
159. L.A. Carlson Niaspan, the prolonged release preparation of nicotinic acid (niacin), the broad-spectrum lipid drug Int. J. Clin. Pract. 58 2004 706 713
160. B.G. Brown, X.Q. Zhao, A. Chait, L.D. Fisher, M.C. Cheung, J.S. Morse, A.A. Dowdy, E.K. Marino, E.L. Bolson, P. Alaupovic, J. Frohlich, and J.J. Albers Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease N. Engl. J. Med. 345 2001 1583 1592
161. T. Rubic, M. Trottmann, and R.L. Lorenz Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin Biochem. Pharmacol. 67 2004 411 419
162. C.D. Meyers, and M.L. Kashyap Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection Curr. Opin. Cardiol. 19 2004 366 373
163. T. Maejima, H. Yamazaki, T. Aoki, T. Tamaki, F. Sato, M. Kitahara, and Y. Saito Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell Biochem. Biophys. Res. Commun. 324 2004 835 839
164. I. Zanotti, E. Favari, A.C. Sposito, G.H. Rothblat, and F. Bernini Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells Biochem. Biophys. Res. Commun. 321 2004 670 674
165. H. Ando, S. Tsuruoka, H. Yamamoto, T. Takamura, S. Kaneko, and A. Fujimura Effects of pravastatin on the expression of ATP-binding cassette transporter A1 J. Pharmacol. Exp. Ther. 311 2004 420 425
166. H. Sone, H. Shimano, M. Shu, M. Nakakuki, A. Takahashi, M. Sakai, Y. Sakamoto, T. Yokoo, K. Matsuzaka, H. Okazaki, Y. Nakagawa, K.T. Iida, H. Suzuki, H. Toyoshima, S. Horiuchi, and N. Yamada Statins downregulate ATP-binding-cassette transporter A1 gene expression in macrophages Biochem. Biophys. Res. Commun. 316 2004 790 794
167. J. Wong, C.M. Quinn, and A.J. Brown Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux Arterioscler., Thromb., Vasc. Biol. 24 2004 2365 2371
168. G.B. Mancini Antiatherosclerotic effects of calcium channel blockers Prog. Cardiovasc. Dis. 45 2002 1 20
169. K.A. Midtbo Effects of long-term verapamil therapy on serum lipids and other metabolic parameters Am. J. Cardiol. 66 1990 13I 15I
170. S. Suzuki, T. Nishimaki-Mogami, N. Tamehiro, K. Inoue, R. Arakawa, S. Abe-Dohmae, A.R. Tanaka, K. Ueda, and S. Yokoyama Verapamil increases the apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via Liver X receptor-independent mechanism Arterioscler., Thromb., Vasc. Biol. 24 2004 519 525
171. G. Schmitz, H. Robenek, M. Beuck, R. Krause, A. Schurek, and R. Niemann Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms: I. Characterization of cellular lipid metabolism Arteriosclerosis 8 1988 46 56
172. H. Robenek, and G. Schmitz Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms: II. Characterization of intracellular morphologic changes Arteriosclerosis 8 1988 57 67
173. R. Ylitalo Bisphosphonates and atherosclerosis Gen. Pharmacol. 35 2000 287 296
174. H. Koshiyama, Y. Nakamura, S. Tanaka, and J. Minamikawa Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes J. Clin. Endocrinol. Metab. 85 2000 2793 2796
175. R. Ylitalo, J. Monkkonen, and S. Yla-Herttuala Effects of liposome-encapsulated bisphosphonates on acetylated LDL metabolism, lipid accumulation and viability of phagocyting cells Life Sci. 62 1998 413 422
176. D. Strobach, and R.L. Lorenz The bisphosphonate ibandronate stimulates reverse cholesterol transport out of monocytoid cells by enhanced ABCA1 transcription Biochem. Biophys. Res. Commun. 307 2003 23 30
177. G.L. Semenza HIF-1 and human disease: one highly involved factor Genes Dev. 14 2000 1983 1991
178. G.L. Semenza Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology Trends Mol. Med. 7 2001 345 350
179. S.P. Mathupala, A. Rempel, and P.L. Pedersen Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions J. Biol. Chem. 276 2001 43407 43412
180. G.L. Semenza, B.H. Jiang, S.W. Leung, R. Passantino, J.P. Concordet, P. Maire, and A. Giallongo Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1 J. Biol. Chem. 271 1996 32529 32537
181. A. Rivard, L. Berthou-Soulie, N. Principe, M. Kearney, C. Curry, D. Branellec, G.L. Semenza, and J.M. Isner Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity J. Biol. Chem. 275 2000 29643 29647
182. A. Schultz, L. Lavie, I. Hochberg, R. Beyar, T. Stone, K. Skorecki, P. Lavie, A. Roguin, and A.P. Levy Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation Circulation 100 1999 547 552
183. D.J. Manalo, A. Rowan, T. Lavoie, L. Natarajan, B.D. Kelly, S.Q. Ye, J.G. Garcia, and G.L. Semenza Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1 Blood 105 2005 659 669
184. Z. Arany, L.E. Huang, R. Eckner, S. Bhattacharya, C. Jiang, M.A. Goldberg, H.F. Bunn, and D.M. Livingston An essential role for p300/CBP in the cellular response to hypoxia Proc. Natl. Acad. Sci. U. S. A. 93 1996 12969 12973
185. P. Carrero, K. Okamoto, P. Coumailleau, S. O'Brien, H. Tanaka, and L. Poellinger Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha Mol. Cell. Biol. 20 2000 402 415
186. M. Ema, K. Hirota, J. Mimura, H. Abe, J. Yodoi, K. Sogawa, L. Poellinger, and Y. Fujii-Kuriyama Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300 EMBO J. 18 1999 1905 1914
187. G. Schmitz, S. Heimerl, and T. Langmann Zinc finger protein ZNF202 structure and function in transcriptional control of HDL metabolism Curr. Opin. Lipidol. 15 2004 199 208
188. M. Porsch-Ozcurumez, T. Langmann, S. Heimerl, H. Borsukova, W.E. Kaminski, W. Drobnik, C. Honer, C. Schumacher, and G. Schmitz The zinc finger protein 202 (ZNF202) is a transcriptional repressor of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux J. Biol. Chem. 276 2001 12427 12433
189. C. Monaco, C.M. Helmer, E. Caprini, I. Vorechovsky, G. Russo, C.M. Croce, G. Barbanti-Brodano, and M. Negrini Molecular cloning and characterization of ZNF202: a new gene at 11q23.3 encoding testis-specific zinc finger proteins Genomics 52 1998 358 362
190. T. Langmann, C. Schumacher, S.G. Morham, C. Honer, S. Heimerl, C. Moehle, and G. Schmitz ZNF202 is inversely regulated with its target genes ABCA1 and apoE during macrophage differentiation and foam cell formation J. Lipid Res. 44 2003 968 977
191. M.S. Lechner, G.E. Begg, D.W. Speicher, and F.J. Rauscher III Molecular determinants for targeting heterochromatin protein 1-mediated gene silencing: direct chromoshadow domain-KAP-1 corepressor interaction is essential Mol. Cell. Biol. 20 2000 6449 6465
192. C. Schumacher, H. Wang, C. Honer, W. Ding, J. Koehn, Q. Lawrence, C.M. Coulis, L.L. Wang, D. Ballinger, B.R. Bowen, and S. Wagner The SCAN domain mediates selective oligomerization J. Biol. Chem. 275 2000 17173 17179
193. R. Babb, and B.R. Bowen SDP1 is a PPARgamma2 coactivator that binds through its SCAN domain Biochem. J. 370 2003 719 727
194. M.G. Rosenfeld, and C.K. Glass Coregulator codes of transcriptional regulation by nuclear receptors J. Biol. Chem. 276 2001 36865 36868
195. L.P. Freedman Multimeric coactivator complexes for steroid/nuclear receptors Trends Endocrinol. Metab. 10 1999 403 407
196. O. Hermanson, C.K. Glass, and M.G. Rosenfeld Nuclear receptor coregulators: multiple modes of modification Trends Endocrinol. Metab. 13 2002 55 60
197. J. Huuskonen, P.E. Fielding, and C.J. Fielding Role of p160 coactivator complex in the activation of liver X receptor Arterioscler., Thromb., Vasc. Biol. 24 2004 703 708
198. B.L. Wagner, A.F. Valledor, G. Shao, C.L. Daige, E.D. Bischoff, M. Petrowski, K. Jepsen, S.H. Baek, R.A. Heyman, M.G. Rosenfeld, I.G. Schulman, and C.K. Glass Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression Mol. Cell. Biol. 23 2003 5780 5789
199. X. Hu, S. Li, J. Wu, C. Xia, and D.S. Lala Liver X receptors interact with corepressors to regulate gene expression Mol. Endocrinol. 17 2003 1019 1026
200. C. Brendel, K. Schoonjans, O.A. Botrugno, E. Treuter, and J. Auwerx The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity Mol. Endocrinol. 16 2002 2065 2076